Overview

Safety and Efficacy of Antidiabetic Drugs in Recently Diagnosed Patients With Type 2 Diabetes

Status:
Completed
Trial end date:
2020-12-15
Target enrollment:
Participant gender:
Summary
The current study aims to investigate Sitagliptin and vildagliptin efficacy and safety compared to metformin as 1st line options for T2D patients.
Phase:
Phase 4
Details
Lead Sponsor:
Beni-Suef University
Collaborator:
Minia University
Treatments:
Metformin
Sitagliptin Phosphate
Vildagliptin